TIMP1 and breast cancer: Yuan et al. found that breast cancer patients who underwent radiotherapy and chemotherapy post-surgery showed decreased MMP-9 levels and elevated TIMP-1 levels in their serum, which correlated with clinicopathological characteristics [110].